Genomic approaches to the burden of kidney disease in Sub-Saharan Africa: the Human Heredity and Health in Africa (H3Africa) Kidney Disease Research Network

Kidney International

Volumn 90, Issue 1, 2016, Pages 2-5

  Parekh, Rulan S ^m   Rasooly, Rebekah S ^k   Kimmel, Paul ^k  

^a UNIVERSITY OF GHANA   (Ghana)

^b UNIVERSITY OF IBADAN   (Nigeria)

^c UNIVERSITY OF ILORIN   (Nigeria)

^d UNIVERSITY OF ABUJA   (Nigeria)

^e OBAFEMI AWOLOWO UNIVERSITY   (Nigeria)

^f UNIVERSITY OF NIGERIA   (Nigeria)

^g KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

^h ADDIS ABABA UNIVERSITY   (Ethiopia)

ⁱ UNIVERSITY OF NAIROBI   (Kenya)

^j NATIONAL CANCER INSTITUTE   (United States)

^k NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^l UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^m UNIVERSITY HEALTH NETWORK   (Canada)

more..

Author keywords

Africa; APOL 1; chronic kidney disease; genomics

Indexed keywords

ADOLESCENT; AFRICA SOUTH OF THE SAHARA; ALLELE; APOL1 GENE; CASE REPORT; CHRONIC KIDNEY DISEASE; DEATH; DISEASE SEVERITY; ECHOGRAPHY; EDITORIAL; END STAGE RENAL DISEASE; FEMALE; GENE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOMICS; GENOTYPE; HEALTH CARE COST; HEMODIALYSIS; HOSPITALIZATION; HUMAN; KIDNEY DISEASE; LUNG CONGESTION; LUNG EDEMA; ONSET AGE; PRIORITY JOURNAL; AFRICAN TRYPANOSOMIASIS; CHRONIC KIDNEY FAILURE; COMPLICATION; COST OF ILLNESS; ECONOMICS; ETHICS; FATALITY; GENETICS; HEREDITY; MICROBIOLOGY; NEPHROLOGIST; PATHOGENICITY; PREVALENCE; RISK FACTOR; TRYPANOSOMA BRUCEI GAMBIENSE;

APOL1 PROTEIN, HUMAN; APOLIPOPROTEIN L1;

ADOLESCENT; AFRICA SOUTH OF THE SAHARA; ALLELES; APOLIPOPROTEIN L1; COST OF ILLNESS; FATAL OUTCOME; FEMALE; GENOMICS; HEREDITY; HUMANS; KIDNEY FAILURE, CHRONIC; NEPHROLOGISTS; PREVALENCE; PULMONARY EDEMA; RENAL DIALYSIS; RISK FACTORS; TRYPANOSOMA BRUCEI GAMBIENSE; TRYPANOSOMIASIS, AFRICAN; ULTRASONOGRAPHY;

EID: 84988353087     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1016/j.kint.2015.12.059     Document Type: Editorial

References (9)

1. 1 Alleyne, G., Binagwaho, A., Haines, A., et al. Embedding non-communicable diseases in the post-2015 development agenda. Lancet 381:9866 (2013), 566–574.
2. 2 Stanifer, J.W., Jing, B., Tolan, S., et al. The epidemiology of chronic kidney disease in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Glob Health 2:3 (2014), e174–e181.
3. 3 Naicker, S., Burden of end-stage renal disease in sub-Saharan Africa. Clin Nephrol 74:suppl 1 (2010), S13–S16.
4. 4 Arogundade, F.A., Barsoum, R.S., CKD prevention in Sub-Saharan Africa: a call for governmental, nongovernmental, and community support. Am J Kidney Dis 51:3 (2008), 515–523.
5. 5 Ulasi, II, Ijoma, C.K., The enormity of chronic kidney disease in Nigeria: the situation in a teaching hospital in South-East Nigeria. J Trop Med, 2010, 2010, 501957.
6. 6 Parsa, A., Kao, W.H., Xie, D., et al. APOL1 risk variants, race, and progression of chronic kidney disease. N Engl J Med 369:23 (2013), 2183–2196.
7. 7 Rotimi, C., Abayomi, A., Abimiku, A., et al. Research capacity. Enabling the genomic revolution in Africa. Science 344:6190 (2014), 1346–1348.
8. 8 Osafo, C., Raji, Y.R., Burke, D., et al. Human Heredity and Health (H3) in Africa Kidney Disease Research Network: a focus on methods in sub-Saharan Africa. Clin J Am Soc Nephrol 10:12 (2015), 2279–2287.
9. 9 Ulasi, I.I., Tzur, S., Wasser, W.G., et al. High population frequencies of APOL1 risk variants are associated with increased prevalence of non-diabetic chronic kidney disease in the Igbo people from south-eastern Nigeria. Nephron Clin Pract 123:1–2 (2013), 123–128.